Sarosh Rana to Prospective Studies
This is a "connection" page, showing publications Sarosh Rana has written about Prospective Studies.
Connection Strength
1.173
-
Effect of postpartum oral furosemide use on postpartum readmissions and blood pressure trends. Pregnancy Hypertens. 2025 Mar; 39:101199.
Score: 0.120
-
Systematic treatment and management of postpartum hypertension using remote patient monitoring. Pregnancy Hypertens. 2025 Mar; 39:101180.
Score: 0.120
-
Real-world evidence for the utility of serum soluble fms-like tyrosine kinase 1/placental growth factor test for routine clinical evaluation of hospitalized women with hypertensive disorders of pregnancy. Am J Obstet Gynecol. 2025 Apr; 232(4):385.e1-385.e21.
Score: 0.116
-
Patient and provider perception of home blood pressure monitoring kits. Pregnancy Hypertens. 2023 Dec; 34:33-38.
Score: 0.110
-
Use of the angiogenic biomarker profile to risk stratify patients with fetal growth restriction. Am J Obstet Gynecol MFM. 2021 07; 3(4):100394.
Score: 0.093
-
Real life outpatient biomarker use in management of hypertensive pregnancies in third trimester in a low resource SeTting: ROBUST study. Pregnancy Hypertens. 2021 Mar; 23:97-103.
Score: 0.090
-
Activin A and Late Postpartum Cardiac Dysfunction Among Women With Hypertensive Disorders of Pregnancy. Hypertension. 2018 07; 72(1):188-193.
Score: 0.076
-
Prevalence, risk factors and associated complications of postpartum hypertension in rural Haiti. Pregnancy Hypertens. 2017 Oct; 10:135-142.
Score: 0.072
-
Circulating Antiangiogenic Factors and Myocardial Dysfunction in Hypertensive Disorders of Pregnancy. Hypertension. 2016 06; 67(6):1273-80.
Score: 0.066
-
Clinical characterization and outcomes of preeclampsia with normal angiogenic profile. Hypertens Pregnancy. 2013 May; 32(2):189-201.
Score: 0.053
-
Circulating angiogenic factors and risk of adverse maternal and perinatal outcomes in twin pregnancies with suspected preeclampsia. Hypertension. 2012 Aug; 60(2):451-8.
Score: 0.050
-
Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia. Circulation. 2012 Feb 21; 125(7):911-9.
Score: 0.049
-
Reference Range Determination for the sFlt-1/PlGF Ratio in a Diverse Cohort of Pregnant Women in the United States. J Appl Lab Med. 2025 Jul 01; 10(4):937-948.
Score: 0.031
-
Report from a text-based blood pressure monitoring prospective cohort trial among postpartum women with hypertensive disorders of pregnancy. BMC Pregnancy Childbirth. 2024 May 03; 24(1):340.
Score: 0.029
-
The additive role of angiogenic markers for women with confirmed preeclampsia. Am J Obstet Gynecol. 2023 05; 228(5):573.e1-573.e11.
Score: 0.026
-
Antepartum Aspirin Administration Reduces Activin A and Cardiac Global Longitudinal Strain in Preeclamptic Women. J Am Heart Assoc. 2020 06 16; 9(12):e015997.
Score: 0.022
-
Myocardial performance index in hypertensive disorders of pregnancy: The relationship between blood pressures and angiogenic factors. Hypertens Pregnancy. 2017 May; 36(2):161-167.
Score: 0.017
-
Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study. Am J Obstet Gynecol. 2016 Jan; 214(1):108.e1-108.e14.
Score: 0.016
-
Circulating soluble endoglin and placental abruption. Prenat Diagn. 2008 Sep; 28(9):852-8.
Score: 0.010
-
Fetal cheek-to-cheek diameter in the prediction of mode of delivery. Am J Obstet Gynecol. 2005 Apr; 192(4):1205-11; discussion 1211-3.
Score: 0.008